Connection

Laurent Peyrin-Biroulet to Biological Therapy

Back to Details
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Biological Therapy.
Laurent Peyrin-Biroulet
Connection Strength
1.313
Biological Therapy
  1. Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis? Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:17-25.
    View in: PubMed
    Score: 0.514
  2. Surgical rates in the era of biological therapy: up, down or unchanged? Curr Opin Gastroenterol. 2017 Jul; 33(4):246-253.
    View in: PubMed
    Score: 0.485
  3. Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses. Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:43-47.
    View in: PubMed
    Score: 0.129
  4. Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease. Clin Pharmacol Ther. 2017 Oct; 102(4):633-641.
    View in: PubMed
    Score: 0.122
  5. Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply. Aliment Pharmacol Ther. 2018 02; 47(4):540-541.
    View in: PubMed
    Score: 0.032
  6. Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis. Aliment Pharmacol Ther. 2018 02; 47(4):454-465.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.